PIK3CA and cervical cancer: (53) found that ctDNA could detect recurrent metastatic cervical cancer patients with any mutations in PIK3CA, BRAF, GNA11, FBXW7, and CDH1, whose PFS and OS were significantly shorter than those without detectable mutations.